ArticleBritish journal of cancer2026

CDKN1B inactivation impacts ER signaling and drives resistance to endocrine therapy in breast cancer.

Suhail Ahmad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.